News - Sanofi, Global


Current filters:


Popular Filters

Global insulin market expanded to $20.8 billion in 2012


As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular…

Asia-PacificBayerChinaDiabetesEli LillyGlobalMarkets & MarketingNovo NordiskSanofi

Multiple sclerosis market could reach $18.3 billion in 2018


The multiple sclerosis (MS) market is expected to peak at $18.3 billion in 2018, according to healthcare…

AubagioBiogen IdecFinancialGilenyaGlobalNovartisPharmaceuticalSanofiTecfidera

Global diabetes drugs market led by Novo Nordisk and Sanofi


The global diabetes drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

DiabetesGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Pharma vs the world: Big Pharma caught between investors and public


Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Back to top